RKRajesh Karyakarte

Rajesh Karyakarte

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rajesh Karyakarte has a total of 209 co-authors. Here are the top co-authors by number of shared publications:

  • Suvarna Joshi

    Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals Pune IND

    14 shared publications
  • Rashmita Das

    Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals Pune IND

    13 shared publications
  • Sushma Yanamandra

    Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals Pune IND

    9 shared publications
  • Jeanne Agarasen

    Microbiology, Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, IND

    8 shared publications
  • Praveena Pillai

    Microbiology, Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, IND

    8 shared publications
  • Sonali Dudhate

    Microbiology, Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, IND

    7 shared publications

Latest Publications

  • Open Access

    Global Emergence and Spread of the XFG SARS-CoV-2 Variant and Its Clinical Profile Among XFG Patients in Maharashtra, India

    by Rajesh P Karyakarte, Rashmita Das, Sushma Yanamandra, Kalyani Jagarwal, Preeti Pawar, Viswanathan D V, Gilbert Chamy, Vasundhara Singh, Anna Tete, Asawari Koshti, et al.

    Background: In early 2025, changing dominance among Omicron-derived lineages culminated in the emergence of the recombinant XFG variant. XFG exhibited a significant growth advantage, rapidly emerging as the predominant SARS-CoV-2 variant in India and globally, prompting its designation as a Variant Under Monitoring by the World Health Organization in June 2025. This study examines the spread of the XFG variant and describes its clinical characteristics in Maharashtra, India. Methodology: The dataset included 204,603 SARS-CoV-2 genomes from the Global Initiative on Sharing All Influenza Data (GISAID) and 1,089 XFG sequences from India (obtained from the Indian Biological Data Centre (IBDC)), collected between November 1, 2024, and October 31, 2025, to assess the temporal and geographic distribution of XFG in the context of global SARS-CoV-2 circulation. Telephonic interviews were conducted to obtain clinical information for the XFG cases in Maharashtra. All data were recorded and analyzed using Microsoft® Excel (Microsoft Corporation, Redmond, Washington, United States). Results: Among 204,603 global SARS-CoV-2 genomes analyzed, XEC (20.4%) and XFG (18.8%) were the most prevalent lineages, with XFG emerging as a major global driver during mid-to-late 2025. XFG became dominant in North America, Europe, South America, and Africa, accounting for 66-83% of late-phase sequences, while remaining less prevalent in Asia and Oceania (<20%). Globally, the distribution of XFG sublineages was dominated by the parent lineage XFG (71.1%), followed by XFG.3 (12.6%), XFG.1 (5.8%), XFG.3.4.3 (5.4%), XFG.3.4 (3.3%), and XFG.2 (1.8%). In India, among the 1,089 XFG sequences, 27 sublineages were identified, predominantly XFG.3 (45.27%) and XFG.4 (41.78%), with the highest contributions from Gujarat, Maharashtra, West Bengal, and Rajasthan. Maharashtra reported its first XFG detection in early January 2025, followed by a sharp surge during May-June 2025. Clinical evaluation of 99 laboratory-confirmed XFG cases from Maharashtra showed that most patients were symptomatic (92.93%) but experienced predominantly mild illness, commonly presenting with fever, cough, cold, body ache, fatigue, and sore throat. Comorbidities were present in 31.31% of cases, most frequently diabetes mellitus and hypertension. Most patients were managed at home (68.69%), while 31.31% required hospitalization; among these, 61.29% received conservative care, and 38.71% required predominantly non-invasive oxygen support. Vaccination coverage was high (90.91%), with all unvaccinated cases occurring in children aged 0-9 years. Overall outcomes were favorable, with a recovery rate of 95.96% and low mortality (4.04%), confined to elderly patients with significant comorbidities. Conclusion: The XFG variant emerged as the dominant SARS-CoV-2 lineage globally during late 2024-2025 and circulated widely across India, with a brief mid-2025 surge. Despite reduced clinical severity, XFG's rapid spread and diversification highlight ongoing viral adaptability and the need for strengthened, complementary surveillance to detect emerging variants early.


  • Clinical Characteristics, Microbiological Profile and Antimicrobial Resistance Pattern of Bloodstream Infections in Critically Ill Patients: A Cross-sectional Study

    by Prachi Sudhir Dubal, Ashish Sadafale, Vaishali Wabale, Sunil Bhamare, Rajesh Karyakarte

    Introduction: Bloodstream Infections (BSIs) often complicate the outcomes of critically ill patients and are typically associated with high morbidity and mortality rates. There is marked variation reported in the prevalence and antimicrobial resistance patterns of pathogens causing BSIs. Updated and comprehensive data, integrating the microbiological profile and clinical characteristics, may serve as a promising framework for planning and executing management strategies for BSIs in critically ill patients. Aim: To investigate the clinical characteristics, microbiological profile, and antimicrobial resistance patterns of BSIs in critically ill patients. Materials and Methods: This cross-sectional study was conducted over a period of four years (June 2021 to May 2025) in a tertiary care academic hospital. Blood cultures from adult patients (>18 years) with a strong clinical suspicion of sepsis were included. Sepsis was diagnosed based on the criteria for Systemic Inflammatory Response Syndrome (SIRS). Bacterial pathogens isolated from blood cultures were identified, and antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion test on Mueller-Hinton agar. The clinical characteristics of patients were recorded and analysed. Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) version 24.0 (IBM, USA). A p-value <0.05 was considered significant. Results: Out of 15,894 blood cultures received, a total of 2,764 (17.4%) were positive. Risk factors such as the use of corticosteroids and the presence of invasive medical devices were significantly associated with BSIs. Bacterial pathogens were isolated from 2,481 (89.8%) samples, while Candida was isolated from 283 (10.2%) samples. Coagulase-negative Staphylococci 411 (59.1%) were the most common Grampositive cocci (GPC). Klebsiella pneumoniae 642 (50.1%) was the most common Gram-negative bacilli (GNB). Both GPC and GNB demonstrated high resistance to commonly used first- and second-line antimicrobial agents. Conclusion: The overall prevalence of bacterial pathogens was high in BSIs among critically ill patients, with GNB—particularly Klebsiella pneumoniae—being the most prevalent pathogen. The significant antimicrobial resistance demonstrated by both Gram-positive and Gram-negative pathogens is alarming and emphasises the importance of strengthening infection prevention and control practices, along with the effective implementation of enhanced antimicrobial stewardship programs

  • Open Access

    Comparison of coronavirus disease 19 rapid diagnostic test with gold standard real time reverse transcription polymerase chain reaction in omicron wave of pandemic

    by Mayuri Renukadas Gajbhiye, Suvarna Aniruddha Joshi, Pooja Gautam Shah, Sweety Singh, Rashmita Das, Rajesh Prabhakar Karykarte

    Background: The Omicron variant of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the most mutated variant identified and contributed to the third wave of the coronavirus disease-19 (COVID-19) pandemic. Due to its high transmissibility, it has replaced the Delta variant, which was the dominant variant during the second wave of the pandemic. Aims and Objectives: This study aims to evaluate whether the highly transmissible, rapidly multiplying, and frequently transforming Omicron variant of SARS-CoV-2 affects the performance of rapid antigen tests (RAT) in the third wave of the COVID-19 pandemic. Materials and Methods: This retrospective study was conducted in a tertiary care hospital in the initial period of the third wave of the COVID-19 pandemic. Socio-demographic information was collectedfrom 480 patients whose nasopharyngeal swabs were received for both RAT and reverse transcription-polymerase chain reaction (RT-PCR) testing. Results: Male preponderance was seen in all patients’ age groups. Substantial agreement between RAT and gold standard RT-PCR was observed. When samples that tested positive by RAT were further analyzed with RT-PCR, most of them showed a cycle threshold value below 25, indicating a higher viral load. Sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio of the COVID-19 RAT were 46.03%, 99.52%, 93.54%, 92.42%, 95.87%, and 0.54%, respectively. Conclusion: The RAT shows high specificity and good agreement with RT-PCR results, making it suitable as a quick point-of-care screening tool, especially in hospitals and areas with high infection rates. TheOmicron variant did not significantly affect the performance of RAT.

  • Open Access

    Comparison of Broth Disk Elution and Broth Microdilution Methods for Colistin Susceptibility Testing in Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa

    by Priyanka M. Chandankhede, Rajesh P. Karyakarte, Ashish Sadafale, Prashant Patil, Rashmita Das, Sushma Yanamandra, Meghna Palewar, Priyanka M. Chandankhede Sr.

    Background: The increasing prevalence of carbapenem-resistant Enterobacteriaceae (CRE) and Pseudomonas aeruginosa (CRPA) poses a significant challenge to clinical management, particularly in resource-limited settings. Colistin remains one of the last-resort antibiotics for treating these infections; however, its accurate susceptibility testing remains technically challenging. The Broth Microdilution (BMD) method, though recommended as the reference standard, is labor-intensive and not feasible for routine use in most laboratories. This study aims to evaluate the Colistin Broth Disk Elution (CBDE) method as a practical alternative to BMD. Materials and methods: This cross-sectional study was conducted over 18 months (December 2022 to June 2024) at a tertiary care microbiology laboratory in India. A total of 120 non-duplicate CRE and CRPA isolates from clinical specimens were randomly selected and tested for colistin susceptibility using both BMD and CBDE methods. MIC interpretations were based on CLSI 2024 guidelines. Categorical agreement (CA), essential agreement (EA), and error rates were analyzed as per CLSI 2015 recommendations. Results: Out of 120 carbapenem-resistant isolates included in the study, 92 (76.67%) were CRE and 28 (23.33%) were CRPA. Colistin resistance was detected in six (5%) and four (3.33%) isolates by BMD and CBDE, respectively. CBDE showed a CA of 98.3% (95% confidence Interval: 94.1%-99.8%) and EA of 100% when compared to BMD, with only two minor errors (1.6%) and no major or very major errors. Conclusion: CBDE demonstrated high categorical agreement with BMD and minimal error and offers a simple, cost-effective alternative for routine colistin susceptibility testing, especially in low-resource settings where BMD is not feasible.


  • Unusual and Uncommon Presentations of Extrapulmonary Tuberculosis: A Case Series

    by Pooja Shah, Sae Pol, Abhilasha Belpatre, Tejaswini Olambe, Rajesh Karyakarte

    Tuberculosis (TB) is primarily a disease of the lungs; however, Extrapulmonary TB (EPTB) mainly affects the lymph nodes, pleural cavity and spine. Other sites are considered rare and uncommon. Authors present five interesting cases of EPTB from different sites. The first case involved thyroid TB that had spread to the neck. The Cartridge-Based Nucleic Acid Amplification Test (CBNAAT) test was positive. The patient was started on antitubercular treatment and was discharged after undergoing incision and drainage. The second case is of an immunocompetent patient with disseminated TB, which spread from the lungs to the pleura, muscles, subcutaneous tissue and skin, resulting in fistula formation. The CBNAAT was positive, and the Line Probe Assay (LPA) indicated that the strains were sensitive to rifampicin and isoniazid. The third case details a female patient with genital TB who was unable to conceive. An ultrasound examination revealed issues in the adnexa. The CBNAAT was positive (with low levels of Mycobacterium tuberculosis detected, and rifampicin was found to be sensitive), but her sputum sample was negative. The fourth case describes disseminated TB in a seropositive female, where her synovial fluid tested positive and her Computed Tomography (CT) chest findings were suggestive of TB. The fifth case is of abdominal TB in a patient with a history of previous abdominal surgery. Her CBNAAT was positive and she recovered following treatment. In present study, all the cases presented unusual manifestations and the diagnosis was made based on radiological findings combined with microbiological laboratory investigations. Therefore, clinically suspecting these cases and confirming the diagnosis through microbiological tests is critically important.

  • Unusual and Uncommon Presentations of Extrapulmonary Tuberculosis: A Case Series

    by Pooja Shah, Sae Pol, Abhilasha Belpatre, Tejaswini Olambe, Rajesh Karyakarte

    Tuberculosis (TB) is primarily a disease of the lungs; however, Extrapulmonary TB (EPTB) mainly affects the lymph nodes, pleural cavity and spine. Other sites are considered rare and uncommon. Authors present five interesting cases of EPTB from different sites. The first case involved thyroid TB that had spread to the neck. The Cartridge-Based Nucleic Acid Amplification Test (CBNAAT) test was positive. The patient was started on antitubercular treatment and was discharged after undergoing incision and drainage. The second case is of an immunocompetent patient with disseminated TB, which spread from the lungs to the pleura, muscles, subcutaneous tissue and skin, resulting in fistula formation. The CBNAAT was positive, and the Line Probe Assay (LPA) indicated that the strains were sensitive to rifampicin and isoniazid. The third case details a female patient with genital TB who was unable to conceive. An ultrasound examination revealed issues in the adnexa. The CBNAAT was positive (with low levels of Mycobacterium tuberculosis detected, and rifampicin was found to be sensitive), but her sputum sample was negative. The fourth case describes disseminated TB in a seropositive female, where her synovial fluid tested positive and her Computed Tomography (CT) chest findings were suggestive of TB. The fifth case is of abdominal TB in a patient with a history of previous abdominal surgery. Her CBNAAT was positive and she recovered following treatment. In present study, all the cases presented unusual manifestations and the diagnosis was made based on radiological findings combined with microbiological laboratory investigations. Therefore, clinically suspecting these cases and confirming the diagnosis through microbiological tests is critically important.

  • Open Access

    Human Papilloma Virus Infection and Vaginal Microbiome Profiles in Pre-menopausal Women: A Cross-Sectional Study

    by Smriti Shende, Rashmita Das, Suvarna Joshi, Sushma Yanamandra, Nyabom Taji, Rajesh P. Karyakarte

    Background: Cervical cancer is a common cancer among women worldwide, especially in low- and middle-income countries. Persistent infection with high-risk human papillomavirus (HR-HPV) largely drives the development of cervical cancer. While Lactobacillus-dominant communities are considered protective, dysbiosis, marked by reduced Lactobacilli and increased anaerobic diversity (community state type (CST)-IV), may promote viral persistence. This study aims to assess HR-HPV prevalence and compare vaginal microbiome profiles in women with suspected HPV infection and healthy controls. Material and methods: Vaginal swabs were collected from pre-menopausal women with clinically suspected HPV infection and healthy controls. Samples underwent HR-HPV detection using the Truenat® HPV-HR RT-PCR (real-time polymerase chain reaction) assay (Molbio Diagnostics Limited, Goa, India). Vaginal microbiome profiling was performed using 16S rRNA gene amplicon sequencing on the GridION platform (Oxford Nanopore Technologies plc, Oxford, United Kingdom). Taxonomic classification was carried out using the EPI2ME 16S workflow with Kraken2 (Johns Hopkins University, Baltimore, Maryland, United States), and CSTs were assigned using the VALENCIA (VAginaL community state typE Nearest CentroId clAssifier) algorithm. Statistical analyses and microbial community comparisons were performed using MicrobiomeAnalyst (Xia Lab, Sainte-Anne-de-Bellevue, Quebec, Canada). Results: A total of 86 clinically suspected HPV cases and 63 healthy pre-menopausal controls were enrolled. Overall, high-risk HPV (HPV 16/31 and HPV-18/45) was detected in 11.6% (10/86) of cases, with no positivity in the control group. Vaginal microbiome profiling revealed significantly higher alpha diversity in women with inflammatory cytology compared to healthy controls, and increased Shannon and Simpson diversity indices in HPV-positive and inflammatory groups. Beta diversity analysis showed distinct microbial clustering between all groups. Taxonomic analysis demonstrated a predominance of Lactobacillus spp. in healthy individuals, particularly Lactobacillus crispatus and Lactobacillus iners, whereas disease groups showed increased abundance of Pseudomonas, Rheinheimera, and Agrobacterium. CST-I was more common in healthy controls (7/17, 41.2%), while CST-IV-linked to dysbiosis-was predominant among suspected cases (9/21, 47.6%). Linear discriminant analysis effect size (LEfSe) analysis identified Lactobacillus, Anaerococcus, and Dialister as key genera in healthy individuals, whereas Pseudomonas, Rhizobium, and Rheinheimera were enriched in HPV-positive and inflammatory smear groups, highlighting potential microbial biomarkers of vaginal dysbiosis. Conclusion: These findings underscore the importance of vaginal microbiome composition in cervical health and support further investigation into microbial biomarkers for early detection and targeted interventions in HPV-associated disease.


  • Open Access

    Detection of Resistant Prevalent Genes for Mycobacterium Tuberculosis by Line Probe Assay

    by Tejaswini A. Olambe, Pooja G. Shah, Sae Pol, Vaishali Gaikwad, Bhakti Karmalkar, Rajesh Karyakarte

    Background: The emergence of drug-resistant Mycobacterium tuberculosis (Mtb) strains especially MDR-TB and indeed XDR-TB is a real threat to achieving TB control. Rapid diagnosis of mutations in drug-resistant strains has vital importance in the prognosis. The aim was to identify mutations responsible for drug resistance in Mtb strains derived from patients with tuberculosis using the line probe assay (LPA) method. Materials and Methods: Samples from 191 pulmonary and extrapulmonary Mtb-positive patients by GeneXpert-CBNAAT were collected in 50 ml sterile Falcon tube from MDR-TB suspects. Specimens were decontaminated, and the LPA test was done. Band pattern analysis of LPA strips was performed as per manufacturer’s instructions. Results: Out of total samples, 24 (12.6%) were rifampicin resistant on GeneXpert-CBNAAT. Samples resistant to first line drugs were 31 (16%); among them, 19 were MDR-TB. In 86.36% of specimens, mutation in rpoB gene was at 531-533 codons and Ser531Leu mutation. A total 96% of specimen resistant to isoniazide were high-level resistance, diagnosed by mutation in katG gene. In katG gene, 68% of mutants have S315T1 mutation and 32% have hybrid, i.e., S315T1 and S315T2 mutation. In inhA gene, hybrid mutation at -8 and -15, -16, i.e., C15T and A16G mutations were seen. Out of 31 specimens resistant to first-line drugs, 8 (25%) were resistant to second-line drugs. Most common mutations seen in gyrA and rrs genes were D94N/Y and A1401G, respectively. Conclusion: Rifampicin resistance appears to be an effective marker of MDRTB. Mutation pattern of resistant genes in MTB positive specimens was in line with the literature.

  • Open Access

    Impact of COVID-19 pandemic on tuberculosis

    by Sae Pol, Pooja Shah, Vaishali Gaikwad, Sujata Dharmshale, Mansi Rajmane, Rajesh Karyakarte

    Background: Tuberculosis (TB) is a disease of the respiratory system that spreads when a patient coughs, sneezes, or spits. COVID-19, another respiratory disease, created havoc in 2020 and 2021. During this pandemic, the whole healthcare system was diverted into COVID-19 patient care. It is important to determine what the status of TB ...

  • Open Access

    Predictive metabolite signatures for risk of progression to active TB from QuantiFERON supernatants of household contacts of TB patients

    by Evangeline Ann Daniel, Shubham Upadhyay, Murugesan Selvachithiram, Sathyamurthi Pattabiraman, Brindha Bhanu, Amsaveni Sivaprakasam, Vandana Kulkarni, Rajesh Karyakarte, Sanjay Gaikwad, Mandar Paradkar, et al.

    The identification of individuals with the greatest risk of progression to active tuberculosis (TB) disease from the huge reservoir of Mycobacterium tuberculosis (Mtb) infected individuals continues to remain an arduous ascent in the global effort to control TB. In a two-year prospective study, we analysed metabolic profiles in the unstimulated and TB antigen stimulated QuantiFERON supernatants of 14 healthy household contacts (HHCs) who progressed to TB disease (Progressors) and 14 HHCs who remained healthy (Non-Progressors). We identified 21 significantly dysregulated metabolites in the TB antigen-stimulated QuantiFERON supernatants of Progressors, of which the combination of Malic acid and N-Arachidonoylglycine had maximum AUC of 0.99. Eighteen significantly dysregulated metabolites were identified in the unstimulated QuantiFERON supernatants of Progressors, among which the combination of Orotic acid and the phosphatidylcholines PC (O-34:1), PC (O-18:1(9Z)/16:0), PC (O-18:1(11Z)/16:0) had the maximum AUC of 0.98. Most of the dysregulated metabolites belonged to the pathways of fatty acid metabolism, lipid metabolism and nitric oxide metabolism. Validation of these metabolic signatures in large, diverse cohorts would pave way for the development of a robust test that can identify individuals at high risk of TB for targetted intervention of TB disease.